Vanzan, D.F.; Goma, E.P.; Locatelli, F.R.; Honorio, T.d.S.; Furtado, P.d.S.; Rodrigues, C.R.; de Sousa, V.P.; Mata dos Santos, H.A.; do Carmo, F.A.; Simon, A.;
et al. Evaluation of Silybin Nanoparticles against Liver Damage in Murine Schistosomiasis mansoni Infection. Pharmaceutics 2024, 16, 618.
https://doi.org/10.3390/pharmaceutics16050618
AMA Style
Vanzan DF, Goma EP, Locatelli FR, Honorio TdS, Furtado PdS, Rodrigues CR, de Sousa VP, Mata dos Santos HA, do Carmo FA, Simon A,
et al. Evaluation of Silybin Nanoparticles against Liver Damage in Murine Schistosomiasis mansoni Infection. Pharmaceutics. 2024; 16(5):618.
https://doi.org/10.3390/pharmaceutics16050618
Chicago/Turabian Style
Vanzan, Daniel Figueiredo, Ester Puna Goma, Fernanda Resende Locatelli, Thiago da Silva Honorio, Priscila de Souza Furtado, Carlos Rangel Rodrigues, Valeria Pereira de Sousa, Hilton Antônio Mata dos Santos, Flávia Almada do Carmo, Alice Simon,
and et al. 2024. "Evaluation of Silybin Nanoparticles against Liver Damage in Murine Schistosomiasis mansoni Infection" Pharmaceutics 16, no. 5: 618.
https://doi.org/10.3390/pharmaceutics16050618
APA Style
Vanzan, D. F., Goma, E. P., Locatelli, F. R., Honorio, T. d. S., Furtado, P. d. S., Rodrigues, C. R., de Sousa, V. P., Mata dos Santos, H. A., do Carmo, F. A., Simon, A., Pyrrho, A. d. S., Ribeiro, A. J., & Cabral, L. M.
(2024). Evaluation of Silybin Nanoparticles against Liver Damage in Murine Schistosomiasis mansoni Infection. Pharmaceutics, 16(5), 618.
https://doi.org/10.3390/pharmaceutics16050618